Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] Read More »
Articles by : William Newton, Associate Editor/Senior Writer
Federal regulators are exploring a data repository to identify 340B claims to exclude from certain Medicare inflation rebates in 2026 [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Johnson & Johnson (J&J) earlier today sued the federal government to establish a 340B rebate model, marking the latest escalation [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Arkansas state officials and providers are urging the U.S. Supreme Court not to take up a drug industry trade group’s [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major group purchasing organization (GPO) is suing the federal government over a policy that it claims unlawfully restricts how [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Eli Lilly is backing Sanofi’s lawsuit to compel the federal government to release all 340B contract pharmacy agreements, arguing that [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Boehringer Ingelheim (BI) will begin requiring all 340B covered entities to submit claims data to continue accessing 340B drugs [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] Read More »